BiOptix, Inc.
(XNAS : APPY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.26%83.050.9%$973.90m
KITEKite Pharma, Inc.
0.05%179.3816.1%$742.41m
CELGCelgene Corporation
0.52%144.641.1%$500.32m
AMGNAmgen Inc.
0.25%186.221.1%$484.36m
BIIBBiogen Inc.
-0.14%318.031.2%$421.79m
REGNRegeneron Pharmaceuticals, Inc.
1.42%438.862.7%$359.37m
ALNYAlnylam Pharmaceuticals, Inc
2.07%116.1610.7%$250.82m
ALXNAlexion Pharmaceuticals, Inc.
0.36%143.341.9%$229.81m
JUNOJuno Therapeutics, Inc.
-4.80%42.9814.6%$225.42m
VRTXVertex Pharmaceuticals Incorporated
-1.24%149.381.9%$208.74m
INCYIncyte Corporation
-1.21%109.512.6%$205.14m
ILMNIllumina, Inc.
-0.55%200.313.5%$158.54m
BLUEBluebird Bio, Inc.
1.09%130.1519.3%$142.98m
BMRNBioMarin Pharmaceutical Inc.
-0.53%94.454.4%$136.66m
CLVSClovis Oncology, Inc.
-3.00%76.2018.0%$132.34m

Company Profile

BiOptix, Inc. is a vitro diagnostic company. The company focuses on the commercializing of its blood-based test to serve as an adjunctive test in the diagnosis and treatment of acute appendicitis in children adolescent and young adult patients. The company was founded on July 24, 2000 and is headquartered in Boulder, CO.